Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer.

Breast cancer research and treatment - 1 Feb 2012

Shi Hong, Bevier Melanie, Johansson Robert, Enquist-Olsson Kerstin, Henriksson Roger, Hemminki Kari, Lenner Per, Försti Asta

Abstract excerpt

MYBL2 is a transcription factor, which regulates the expression of genes involved in cancer progression. In this study, we investigated whether putative functional variants in genes regulating MYBL2 (E2F1, E2F3 and E2F4) or in genes, which are regulated by MYBL2 (BCL2, BIRC5, COL1A1, COL1A2, COL5A2, ERBB2, CLU, LIN9 and TOP2A) affect breast cancer (BC) susceptibility and clinical outcome. Twenty-eight SNPs were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clusterin
Share to Gene Regulatory Networks

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, bcl-2

Share to Inhibitor of Apoptosis Proteins

Share to Survival Analysis

Share to Survivin

Share to Sweden

Share to Trans-Activators

Source

Identifiers

PMID: 22037783
DOI: 10.1007/s10549-011-1826-2

Genes

BCL2
MYBL2
CLU
ERBB2
LIN9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer.PMID 22037783Read ↗

MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential.Semantic proximity Read ↗

The role of genetic breast cancer susceptibility variants as prognostic factors.Semantic proximity Read ↗

Characterization of MYBL1 Gene in Triple-Negative Breast Cancers and the Genes’ Relationship to Alterations Identified at the Chromosome 8q LociSemantic proximity Read ↗

Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.Semantic proximity Read ↗

Genetic variations in 3'UTRs of SMUG1 and NEIL2 genes modulate breast cancer risk, survival and therapy response.Semantic proximity Read ↗

Genetic interactions between INPP4B and RAD50 is prognostic of breast cancer survival.Semantic proximity Read ↗

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerSemantic proximity Read ↗

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Semantic proximity Read ↗

Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome.Semantic proximity Read ↗

Effect of functional variant rs11466313 on breast cancer susceptibility and TGFB1 promoter activity.Semantic proximity Read ↗

FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.Semantic proximity Read ↗

Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.